1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Multiple Sclerosis

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Multiple Sclerosis in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (22.22)	18.7374
1990's	3 (33.33)	18.2507
2000's	1 (11.11)	29.6817
2010's	2 (22.22)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Barakat, D; Braitch, M; Constantinescu, CS; Edwards, LJ; Fox, SC; Gran, B; Midgley, A; Nebozhyn, M; Nichols, C; Robins, RA; Showe, LC	1
Cao, L; Chen, S; Ma, CG; Tang, J; Wang, Q; Xiao, BG; Xiao, W; Yu, WB	1
Au, C; Dukhinova, M; Lau, AY; Ponomarev, ED; Starossom, SC; Veremeyko, T; Weiner, HL; Yung, AW	1
Kira, J	1
Brochet, B; Confavreux, C; Guinot, P; Lavergne, V; Orgogozo, JM; Rumbach, L	1
Arese, M; Bargnani, C; Bussolino, F; Callea, L; Orlandini, A; Priori, A	1
Brochet, B; Dartigues, JF; Guinot, P; Henry, P; Loiseau, P; Orgogozo, JM	1
Belin, J; Khan, SN; Sidey, M; Smith, AD; Zilkha, KJ	1

Trials

2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Multiple Sclerosis

Article	Year
Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:3 Topics: Activities of Daily Living; Acute Disease; Adult; Diterpenes; Double-Blind Method; Female; Ginkgolides; Humans; Lactones; Male; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Recurrence; Severity of Illness Index; Treatment Outcome	1995
[Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis]. Revue neurologique, 1992, Volume: 148, Issue:4 Topics: Adult; Diterpenes; Female; Ginkgolides; Humans; Lactones; Male; Multiple Sclerosis; Neurologic Examination; Pilot Projects; Platelet Activating Factor	1992

Article

Year

Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:3

Topics: Activities of Daily Living; Acute Disease; Adult; Diterpenes; Double-Blind Method; Female; Ginkgolides; Humans; Lactones; Male; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Recurrence; Severity of Illness Index; Treatment Outcome

1995

[Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis].

Revue neurologique, 1992, Volume: 148, Issue:4

Topics: Adult; Diterpenes; Female; Ginkgolides; Humans; Lactones; Male; Multiple Sclerosis; Neurologic Examination; Pilot Projects; Platelet Activating Factor

1992

Other Studies

7 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Multiple Sclerosis

Article	Year
PAF-R on activated T cells: Role in the IL-23/Th17 pathway and relevance to multiple sclerosis. Immunobiology, 2021, Volume: 226, Issue:1 Topics: Adult; Cells, Cultured; Female; Humans; Interleukin-17; Interleukin-23; Lymphocyte Activation; Male; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; T-Lymphocytes; Th17 Cells; Tissue Array Analysis	2021
The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation. International immunopharmacology, 2019, Volume: 70 Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Cells, Cultured; Cellular Microenvironment; Chemotaxis; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Ginkgolides; Humans; Lactones; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Platelet Activating Factor; T-Lymphocytes, Regulatory; Th1-Th2 Balance; Th17 Cells	2019
Platelets Play Differential Role During the Initiation and Progression of Autoimmune Neuroinflammation. Circulation research, 2015, Oct-09, Volume: 117, Issue:9 Topics: Adult; Animals; Blood Platelets; CD4-Positive T-Lymphocytes; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coculture Techniques; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Flow Cytometry; Humans; Interferon-gamma; Interleukin-17; Male; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron, Scanning; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Platelet Factor 4; Serotonin	2015
[Multiple sclerosis]. Rinsho shinkeigaku = Clinical neurology, 2005, Volume: 45, Issue:11 Topics: Humans; Interleukin-17; Magnetic Resonance Imaging; Multiple Sclerosis; Neutrophils; Optic Nerve; Platelet Activating Factor; Spinal Cord; Vascular Endothelial Growth Factor A	2005
Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. Journal of neuroimmunology, 1999, Feb-01, Volume: 94, Issue:1-2 Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood-Brain Barrier; Capillaries; Child; Disease Progression; Female; Gadolinium; Gas Chromatography-Mass Spectrometry; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Recurrence	1999
Immunomodulation: other approaches. Transplantation proceedings, 1988, Volume: 20, Issue:1 Suppl 1 Topics: Animals; Daunorubicin; Female; Graft Enhancement, Immunologic; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Multiple Sclerosis; Placenta; Platelet Activating Factor; Pregnancy; Rabbits; Rats; Transplantation Immunology	1988
Response to platelet-activating factor of platelets from patients with multiple sclerosis. Acta neurologica Scandinavica, 1985, Volume: 71, Issue:3 Topics: Acetophenones; Blood Platelets; Calcium; Humans; Indomethacin; Multiple Sclerosis; Platelet Activating Factor; Platelet Aggregation; Verapamil	1985